Objective: Vascular Ehlers-Danlos syndrome (VEDS) is a rare connective tissue disorder with >700 mutations in the COL3A1 gene affecting collagen type III production. Limited data exist regarding the consequent aortic and branch vessel aneurysms and dissections, presentation, and treatment outcomes. This study aimed to provide a description of a contemporary cohort of patients diagnosed with VEDS.
Objective: Vascular Ehlers-Danlos syndrome (VEDS) is a rare connective tissue disorder with >700 mutations in the COL3A1 gene affecting collagen type III production. Limited data exist regarding the consequent aortic and branch vessel aneurysms and dissections, presentation, and treatment outcomes. This study aimed to provide a description of a contemporary cohort of patients diagnosed with VEDS.
Methods: This was a multi-institutional retrospective cohort study of patients diagnosed with VEDS between 2000 and 2015. Demographics, family history, diagnosis modality, COL3A1 mutations, vascular disease, and management data were collected. Data were presented as median and ranges. Patients with confirmed causative COL3A1 mutations were analyzed for vascular disease.
Results: Eleven institutions identified 173 (35.3% male) patients with VEDS. Median age at diagnosis was 26.5 (range, 0.1-81) years by genetic testing, skin biopsy, and clinical criteria in 63%, 3%, and 18% of the cases, respectively. In 16.2%, the diagnosis method was unknown. A family history of confirmed or suspected VEDS, sudden death, stroke, or myocardial infarction was documented in 47.4% of the cases. Arterial dissections or aneurysms were diagnosed in 81 cases (51.9% male). At the time of data collection, 11.6% of the patients died at a median age of 37 (range, 19-70) years, with 95% due to vascular complications. COL3A1 mutation data were available for 79 cases (46.9% male, 5 null mutations). In 15.2% of the cases, the COL3A1 mutations were found to be noncausative. Among those with a causative mutation, 42 (62.9%) were diagnosed with arterial dissections or aneurysms (50% male, 3 null mutations) at a median age of 31.5 (range, 12-79) years. This involved the carotid/vertebral, mesenteric/renal, and iliac arteries in 35.7%, 47.6%, and 31% of the cases, respectively. Aortic involvement occurred in 23.8% of the cases. Mortality in this group was 16.7% at a median age of 43 (range, 22-70) years. Vascular interventions were undertaken in 15 (35.7%) cases (10 open, 5 endovascular), of which 3 were for rupture (thoracic aorta, abdominal aorta, and splenic artery).
Conclusions: This is a large, multi-institutional descriptive study of patients diagnosed with VEDS. The study highlights the importance of establishing a precise diagnosis by confirming a causative COL3A1 mutation. This is a first step toward an accurate understanding of the disease and operative outcomes, thus facilitating clear guidelines for management. Objective: Isolated spontaneous dissection of the superior mesenteric artery (SMA) and celiac artery (CA) remains a rare condition but has been increasingly noted incidentally on diagnostic imaging. We sought to study the natural history and outcomes of patients presenting with isolated spontaneous mesenteric artery dissections (SMADs), hypothesizing that most SMADs can be treated nonoperatively.
Methods: This was a single-center retrospective review of patients presenting with the diagnosis of SMAD between 2006 and 2016. Data analysis included demographics, clinical data, radiologic review, treatment, and outcomes.
Results: A total of 78 patients were found to have isolated CA or SMA dissection diagnosed on computed tomography or magnetic resonance imaging. Average age was 56 years (range, 26-86); 80% were male. Nine patients (12%) had underlying arterial disease; five had fibromuscular dysplasia, and four had segmental arterial mediolysis. The majority, 64%, presented with symptoms including abdominal pain, back pain, and chest pain; the remaining 36% were asymptomatic. Combined SMA and CA dissection was found in 14 (18%) patients, whereas 33 (42%) presented with isolated CA dissection and 31 (40%) presented with isolated SMA dissection. Only four patients required intervention. Mesenteric bypass was performed in two patients, and SMA endarterectomy with patch angioplasty was performed in one patient for signs of bowel ischemia. No patient required bowel resection. The two bypasses were anastomosed to a branch of the SMA, and complete lumen restoration was seen on long-term imaging follow-up (Fig) . One patient underwent stent grafting of the CA and hepatic artery for aneurysmal degeneration 1 month after diagnosis. The remaining 74 patients were managed nonoperatively; 40 (55%) were treated with a short course of anticoagulation, 23 (31%) were treated with antiplatelet therapy, and 10 (14%) were treated with observation alone. No other later interventions or recurrences were noted during a mean follow-up period of 21 months.
Conclusions: Whereas isolated SMAD poses a risk of visceral ischemia, most patients presenting with this diagnosis can be treated nonoperatively with a short course of antiplatelet or anticoagulant therapy. Indications for surgical intervention include bowel ischemia and aneurysmal degeneration. Objective: The objective of this study was to delineate the specific types of waveforms that exist in type II endoleaks (T2ELs) and their effect on the aneurysmal sac size. . He was treated with anticoagulation, but over a period of 9 days, he progressed to complete SMA occlusion with symptoms of bowel ischemia (B). He was treated with mesenteric bypass to a branch of the SMA with restoration of low to the true lumen (C).
